A widely available drug used to treat alcoholism has potential as a COVID-19 treatment, researchers say.

The study was observational, so it doesn’t establish a cause-and-effect link between disulfiram and COVID-19 infection and outcomes.

However, the results are encouraging enough to warrant further study and clinical testing, according to researchers at Harvard Medical School and Boston Children’s Hospital.

“This is a great candidate for a repurposed drug.”